4//SEC Filing
New Leaf Ventures III, L.P. 4
Accession 0000899243-21-032748
CIK 0001708493other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:15 PM ET
Size
17.5 KB
Accession
0000899243-21-032748
Insider Transaction Report
Form 4
Transactions
- Purchase
Common Stock
2021-01-11$17.00/sh+235,294$3,999,998→ 913,860 total(indirect: See footnote)
Holdings
- 2,242,839(indirect: See footnote)
Common Stock
Transactions
- Purchase
Common Stock
2021-01-11$17.00/sh+235,294$3,999,998→ 913,860 total(indirect: See footnote)
Holdings
- 2,242,839(indirect: See footnote)
Common Stock
New Leaf BPO Management II, L.L.C
10% Owner
Transactions
- Purchase
Common Stock
2021-01-11$17.00/sh+235,294$3,999,998→ 913,860 total(indirect: See footnote)
Holdings
- 2,242,839(indirect: See footnote)
Common Stock
New Leaf Ventures III, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2021-01-11$17.00/sh+235,294$3,999,998→ 913,860 total(indirect: See footnote)
Holdings
- 2,242,839(indirect: See footnote)
Common Stock
New Leaf BPO Associates II, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2021-01-11$17.00/sh+235,294$3,999,998→ 913,860 total(indirect: See footnote)
Holdings
- 2,242,839(indirect: See footnote)
Common Stock
Transactions
- Purchase
Common Stock
2021-01-11$17.00/sh+235,294$3,999,998→ 913,860 total(indirect: See footnote)
Holdings
- 2,242,839(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]These shares are held directly by New Leaf Ventures Biopharma Opportunities II, L.P. ("BPO-II"). The general partner of BPO-II is New Leaf BPO Associates II, L.P. ("NLBA-II"). The general partner of NLBA-II is New Leaf BPO Management II, L.L.C. ("BPO Management-II"). Each of NLBA-II and BPO Management-II disclaim beneficial ownership of these securities and this report shall not be deemed an admission that NLBA-II or BPO Management-II are beneficial owners of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein.
- [F2]Each of Ronald M. Hunt, a member of the Issuer's board of directors, and Vijay K. Lathi are the managers of BPO Management-II (the "BPO-II Managers") and may be deemed to have shared voting and investment power with respect to these securities. Each of the BPO-II Managers disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F3]These shares are held directly by New Leaf Ventures III, L.P. ("NLV-III" and together with BPO-II, the "NLV Funds"). The general partner of NLV-III is New Leaf Venture Associates III, L.P. ("NLVA-III"). The general partner of NLVA-III is New Leaf Venture Management III, L.L.C. ("Management-III"). Each of NLVA-III and Management-III disclaim beneficial ownership of these securities and this report shall not be deemed an admission that NLVA-III or Management-III are beneficial owners of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein.
- [F4]Each of Ronald M. Hunt, a member of the Issuer's board of directors, and Vijay K. Lathi, are the managers of Management-III (the "NLV-III Managers") and may be deemed to have shared voting and investment power with respect to these securities. Each of the NLV-III Managers disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001625653
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:15 PM ET
- Size
- 17.5 KB